Jefferies profit misses estimate on weak equity underwriting; eyes rebound later in 2025

Jefferies reported Q2 net earnings of $88 million (40 cents/share), missing analyst estimates, as a halving of equity underwriting revenue outweighed a 61% increase in merger advisory fees. While early-quarter activity was hampered by U.S. policy and geopolitical uncertainty, the investment bank observed a significant recovery in investor confidence and transaction discussions since May. President Brian Friedman noted diminished uncertainty and a rising backlog, anticipating improved results in the third and fourth quarters, offering an early read on broader Wall Street dealmaking trends.

Analysis

Jefferies reported second-quarter earnings that missed analyst estimates, with net earnings of $0.40 per share against an expected $0.44. The shortfall was primarily driven by a 50% year-over-year decline in equity underwriting revenue to $122.4 million, which the bank attributed to geopolitical and policy uncertainty that dampened activity during the first two months of the quarter. This weakness was partially offset by a significant bright spot in advisory services, where revenue climbed 61% to $457.9 million, suggesting market share gains in M&A. The capital markets business remained largely stable, with revenue dipping just 0.4%. Despite the earnings miss and a subsequent 2% drop in the stock in extended trading, management provided a highly optimistic outlook. President Brian Friedman noted that uncertainty has "diminished significantly" since May, leading to a stronger backlog and increased client dialogue, which he expects to drive "even better results in the third and fourth quarters." This commentary positions Jefferies' results as a crucial bellwether for a potential, albeit delayed, recovery in dealmaking across Wall Street.

Key Decisions for Investors

• Investors should weigh the current earnings miss and weak underwriting performance against management's strong conviction in a second-half 2025 rebound, making the credibility of this forward guidance a key factor in any investment thesis.
• Consider the firm's demonstrated strength in advisory revenue, which grew 61%, as a positive indicator of its competitive positioning in an M&A recovery, while monitoring the more volatile equity underwriting segment for signs of a confirmed market turnaround.
• Use Jefferies' commentary on recovering investor confidence and a growing deal pipeline since May as a leading indicator for the health of the broader investment banking sector ahead of upcoming earnings reports from rivals like Goldman Sachs and Morgan Stanley.